WASHINGTON (OSV News) — President Donald Trump on May 12 confirmed that Marty Makary, the embattled FDA commissioner criticized by pro-life advocates and others, will depart from his post.
Pro-life groups were among Makary’s critics after the FDA’s approval during his tenure of a new generic form of mifepristone — a pill commonly, but not exclusively, used for early ab...